SNP ID | Position | Alleles | Trait | Variation Type |
---|---|---|---|---|
rs10412340 | chr19:46718501 (GRCh38.p7) | G>A | alcohol dependence | SNV(Single Nucleotide Variation) |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
PTBP1 | 0.754 |
PRICKLE3 | 0.753 |
NFKB2 | 0.748 |
SCARF1 | 0.74 |
RELA | 0.737 |
HDAC7 | 0.736 |
TOR4A | 0.735 |
FERMT3 | 0.731 |
VASP | 0.73 |
PPP1R18 | 0.728 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
SLC7A4 | -0.389 |
SMIM18 | -0.361 |
CNTN6 | -0.36 |
PPEF1 | -0.357 |
SPHKAP | -0.351 |
AARD | -0.348 |
GRIN3A | -0.345 |
KNCN | -0.338 |
FSTL5 | -0.337 |
DRD5 | -0.335 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PRKD2 mRNA" | 27291303 |
C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PRKD2 mRNA" | 19114083 |
C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of PRKD2 mRNA" | 21346803 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of PRKD2 mRNA | 19770486 |
D001151 | Arsenic | Arsenic affects the expression of PRKD2 mRNA | 18414638 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of PRKD2 mRNA | 21632981 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of PRKD2 mRNA | 21569818|2222880 |
C044887 | beta-methylcholine | beta-methylcholine affects the expression of PRKD2 mRNA | 21179406 |
C006780 | bisphenol A | bisphenol A affects the expression of PRKD2 mRNA | 25181051 |
D002220 | Carbamazepine | Carbamazepine affects the expression of PRKD2 mRNA | 25979313 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of PRKD2 mRNA | 25562108 |
C007262 | deoxynivalenol | deoxynivalenol affects the phosphorylation of PRKD2 protein | 23811945 |
D003976 | Diazinon | Diazinon results in decreased methylation of PRKD2 gene | 22964155 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of PRKD2 mRNA | 27392435 |
D002945 | Cisplatin | Cisplatin results in decreased expression of PRKD2 mRNA | 27594783 |
D002945 | Cisplatin | Cisplatin results in increased expression of PRKD2 mRNA | 27392435 |
C000944 | dicrotophos | dicrotophos results in increased expression of PRKD2 mRNA | 28302478 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of PRKD2 mRNA | 25896364 |
D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in increased expression of PRKD2 mRNA | 23649840 |
C069837 | fullerene C60 | fullerene C60 results in increased expression of PRKD2 mRNA | 19167457 |
D017313 | Fenretinide | Fenretinide results in increased expression of PRKD2 mRNA | 28973697 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of PRKD2 mRNA | 25613284 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of PRKD2 mRNA | 27392435 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of PRKD2 mRNA | 23086925 |
D008694 | Methamphetamine | Methamphetamine results in increased expression of PRKD2 mRNA | 19564919 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of PRKD2 mRNA | 23649840 |
D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in increased expression of PRKD2 mRNA | 24810058 |
C437683 | motexafin gadolinium | motexafin gadolinium results in decreased expression of PRKD2 mRNA | 16357179 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of PRKD2 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of PRKD2 mRNA" | 25554681 |
C028007 | nickel monoxide | nickel monoxide results in increased expression of PRKD2 mRNA | 19167457 |
D010126 | Ozone | Ozone results in decreased expression of PRKD2 mRNA | 12763052 |
C568608 | PCI 5002 | [PCI 5002 co-treated with Zinc] results in increased expression of PRKD2 mRNA | 18593933 |
D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of PRKD2 mRNA | 23892564 |
D012643 | Selenium | Selenium results in increased expression of PRKD2 mRNA | 19244175 |
D012969 | Sodium Fluoride | Sodium Fluoride results in decreased expression of PRKD2 mRNA | 27862939 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of PRKD2 mRNA | 21570461 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of PRKD2 mRNA | 25613284 |
D013849 | Thimerosal | Thimerosal results in decreased expression of PRKD2 mRNA | 27188386 |
C009495 | titanium dioxide | titanium dioxide results in decreased expression of PRKD2 mRNA | 23557971 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of PRKD2 mRNA | 28111298 |
C057693 | troglitazone | troglitazone results in decreased expression of PRKD2 mRNA | 28973697 |
D014520 | Urethane | Urethane results in increased expression of PRKD2 mRNA | 28818685 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of PRKD2 mRNA | 19101580|2317975 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of PRKD2 gene | 29154799 |
D014635 | Valproic Acid | Valproic Acid affects the expression of PRKD2 mRNA | 17292431 |
C111237 | vorinostat | vorinostat results in increased expression of PRKD2 mRNA | 22083351 |
D015032 | Zinc | [PCI 5002 co-treated with Zinc] results in increased expression of PRKD2 mRNA | 18593933 |
D019345 | Zinc Acetate | Zinc Acetate results in decreased expression of PRKD2 mRNA | 16357179 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004672 | protein kinase activity | - | IDA | 17077180 |
GO:0004674 | protein serine/threonine kinase activity | - | IDA | 18440775 |
GO:0004674 | protein serine/threonine kinase activity | - | IMP | 28428613 |
GO:0004674 | protein serine/threonine kinase activity | - | NAS | 11062248 |
GO:0004674 | protein serine/threonine kinase activity | - | TAS | - |
GO:0004697 | protein kinase C activity | - | IEA | - |
GO:0005080 | protein kinase C binding | - | IPI | 28428613 |
GO:0005515 | protein binding | - | IPI | 17962809 19192391 |
GO:0005524 | ATP binding | - | IEA | - |
GO:0046872 | metal ion binding | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0001525 | angiogenesis | - | IEA | - |
GO:0001938 | positive regulation of endothelial cell proliferation | - | IGI | 20497126 |
GO:0001938 | positive regulation of endothelial cell proliferation | - | IMP | 19001381 |
GO:0002250 | adaptive immune response | - | IEA | - |
GO:0006468 | protein phosphorylation | - | IDA | 22228765 |
GO:0006468 | protein phosphorylation | - | NAS | 11062248 |
GO:0007155 | cell adhesion | - | IEA | - |
GO:0008219 | cell death | - | IMP | 17077180 |
GO:0010595 | positive regulation of endothelial cell migration | - | IMP | 19001381 |
GO:0018105 | peptidyl-serine phosphorylation | - | IDA | 18440775 |
GO:0018105 | peptidyl-serine phosphorylation | - | IMP | 28428613 |
GO:0018107 | peptidyl-threonine phosphorylation | - | IMP | 28428613 |
GO:0030148 | sphingolipid biosynthetic process | - | TAS | - |
GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | - | IMP | 19001381 |
GO:0032743 | positive regulation of interleukin-2 production | - | ISS | - |
GO:0032757 | positive regulation of interleukin-8 production | - | IMP | 16928771 |
GO:0032793 | positive regulation of CREB transcription factor activity | - | IGI | 20497126 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | - | IGI | 20497126 |
GO:0035556 | intracellular signal transduction | - | IMP | 18059339 18440775 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | - | IGI | 20497126 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | - | IMP | 18059339 18440775 |
GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway | - | IGI | 20497126 |
GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway | - | IMP | 18440775 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | - | IGI | 20497126 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | - | IMP | 18440775 |
GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway | - | IMP | 19001381 |
GO:0045766 | positive regulation of angiogenesis | - | IGI | 20497126 |
GO:0045766 | positive regulation of angiogenesis | - | IMP | 18440775 19001381 |
GO:0045785 | positive regulation of cell adhesion | - | IMP | 17951978 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | - | IDA | 17077180 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | - | IMP | 18059339 |
GO:0046777 | protein autophosphorylation | - | IDA | 17077180 |
GO:0046777 | protein autophosphorylation | - | TAS | 21488147 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | - | IMP | 18059339 |
GO:0050852 | T cell receptor signaling pathway | - | IDA | 17077180 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | - | ISS | - |
GO:0051091 | positive regulation of DNA-binding transcription factor activity | - | IMP | 19192391 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | - | IMP | 15604256 16928771 28428613 |
GO:0061154 | endothelial tube morphogenesis | - | TAS | 21488147 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | - | ISS | - |
GO:0089700 | protein kinase D signaling | - | IBA | 21873635 |
GO:0089700 | protein kinase D signaling | - | IGI | 20497126 |
GO:1901727 | positive regulation of histone deacetylase activity | - | IGI | 20497126 |
GO:1902533 | positive regulation of intracellular signal transduction | - | IMP | 18440775 |
GO:2000573 | positive regulation of DNA biosynthetic process | - | ISS | - |
GO:2001028 | positive regulation of endothelial cell chemotaxis | - | IMP | 18440775 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005634 | nucleus | - | IDA | 17077180 |
GO:0005654 | nucleoplasm | - | IDA | - |
GO:0005737 | cytoplasm | - | IDA | 17077180 |
GO:0005794 | Golgi apparatus | - | IEA | - |
GO:0005829 | cytosol | - | IDA | - |
GO:0005829 | cytosol | - | TAS | - |
GO:0005886 | plasma membrane | - | IEA | - |
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1430728 | Metabolism | TAS |
R-HSA-1660661 | Sphingolipid de novo biosynthesis | TAS |
R-HSA-428157 | Sphingolipid metabolism | TAS |
R-HSA-556833 | Metabolism of lipids | TAS |
PMID | Title (Year) | Author | Journal |
---|